EWSR1 and neoplasm: EWS-FLI1 translation is modulated by compounds such as Lovastatin or Tunicamycin, which reduce the protein level of EWS-FLI1, thus reducing primary tumor growth (Wang et al., 1999; Herrero-Martin et al., 2011), but increasing a migratory phenotype (Franzetti et al., 2017).